Connect with us

Newsletters

The Capitalist Newsletter – October 7, 2016

Published

on

GOOGLE EXPANDS HARDWARE WITH NEW PHONES

Google had a big unveiling this week. The tech giant launched a new line of hardware, including a powerful line of phones, a virtual reality headset, and a much improved Google Chromecast. But the star of the show was their new smartphone, the Google Pixel. Have they leveled the smartphone playing field at all?

Read The Capitalist’s Take Here…

Read More at CNET

Read More at WIRED


THERANOS SHUTTING DOWN LAB BUSINESS; CUTS 40% OF WORKERS

Just two years after the blood-testing company Theranos was valued at $9 billion, the company has announced that it will close its clinical labs and blood-test centers and cut more than 40 percent of its staff.

Read More From NPR

Read More From Forbes Here

Read More From Vanity Fair Here


TWITTER SHARES PLUMMET AFTER BIDDERS DISAPPEAR

Twitter shares plunged 19% Thursday after published reports said would-be suitors including Google would not bid for the struggling social media company….

Read More From USA Today Here

Read More From Business Insider Here

Read More From Recode Here


Closing Bell

-Thursday, October 6th

Stocks Stay Flat as Investors Wait on Payroll Reports

Big Insider Trades

– Papa John’s International, Inc. (PZZA) CEO John Schnatter Sells $6.25m

-Synergy Resources Corp. (SYRG) CEO Lynn Peterson Buys $400k

Winners & Losers

– Alcoa, Inc. (AA) UP (205.58%) After 1-for-3 Reverse Stock Split

– Alnylam Pharmaceuticals, Inc. (ALNY) Plummets DOWN (48.49%) After Drug Trial Patient Deaths

Most Talked About

Genko Shipping (GNK) A Strong Buy After Announcing Multiple Several Key Agreements

The TIP Sheets

-Thursday, October 6th

-Aurinia Pharmaceuticals, Inc. (AUPH) Soars After Overwhelmingly Positive Lupus Drug Trial Results. Shares Should Continue UP

Unusual Volume

– Alnylam Pharmaceuticals, Inc. (ALNY) Plummets DOWN (48.49%) on 17 Million Shares Traded After Drug Trial Patient Deaths. Stocks Will Continue to Plummet DOWN

Disclaimer: All quotes are in local exchange time.  Real time last sale data provided by The Dow Jones.  The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by S&P Dow Jones Indices LLC and/or its authorized affiliate, and have been licensed for use to The Capitalist.  All content of The Dow Jones branded indices © 2016 S&P Dow Jones Indices LLC and/or its affiliates.  Standard & Poor’s® and S&P® are registered trademarks of Standard & Poor’s Financial Services LLC.  Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC.  The Capitalist is not an affiliate company of S&P Dow Jones Indices LLC, Standard & Poor’s Financial Services LLC, Dow Jones Trademark Holdings LLC, or their respective affiliates.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Continue Reading

Copyright © 2023 The Capitalist. his copyrighted material may not be republished without express permission. The information presented here is for general educational purposes only. MATERIAL CONNECTION DISCLOSURE: You should assume that this website has an affiliate relationship and/or another material connection to the persons or businesses mentioned in or linked to from this page and may receive commissions from purchases you make on subsequent web sites. You should not rely solely on information contained in this email to evaluate the product or service being endorsed. Always exercise due diligence before purchasing any product or service. This website contains advertisements.

Is THE newsletter for…

INVESTORS TRADERS OWNERS

Stay up-to-date with the latest kick-ass interviews, podcasts, and more as we cover a wide range of topics, in the world of finance and technology. Don't miss out on our exclusive content featuring expert opinions and market insights delivered to your inbox 100% FREE!